BSN Capital Partners’s Palantir PLTR Stock Holding History

BSN Capital Partners’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200,105	Closed	-$37.4M	–	41
2026 Q1	$37.4M	Hold	200,105	–	–	0.95%	16
2025 Q4	$37.4M	Buy	+200,105	New	+$36.2M	1.76%	14

Other funds holding PLTR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BSN Capital Partners's PLTR Position: Q2 2026 in Review

BSN Capital Partners sold out of Palantir (PLTR) in Q2 2026, closing a stake of 200,105 shares — an estimated $37.4M sold.

BSN Capital Partners first reported a position in PLTR in Q4 2025 and held it in 2 quarters. The position peaked at $37.4M in Q1 2026. 2,851 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

BSN Capital Partners reported no remaining Palantir position as of Q2 2026 after selling out during the quarter.
BSN Capital Partners sold 200,105 Palantir shares in Q2 2026, an estimated $37.4M.
BSN Capital Partners first reported a position in Palantir in Q4 2025 and held it in 2 quarters.
BSN Capital Partners's Palantir position peaked at $37.4M in Q1 2026.
2,851 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on BSN Capital Partners's 13F filing for Q2 2026, filed 12 Aug 2026.